Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI study

Global brain atrophy was determined in 70 patients suffering from Huntington's disease (HD) and 70 healthy controls, using brain parenchymal fractions calculated from 3D MRI data in a standardized procedure. In HD patients, brain parenchymal fractions were significantly reduced compared to controls in all age groups; the physiological decline with age was less pronounced in HD. However, brain parenchymal fraction values did not allow the prediction of clinical impairment (as assessed by clinical scores). Global brain parenchyma reduction seems to be an early or even constitutional feature of HD, but clinical symptoms appear to reflect regional rather than global atrophy. Overall, MRI-based brain volume quantification correlated with clinical scores clarifies the functional impact of morphological brain alterations.

[1]  A J Thompson,et al.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[2]  E. Pedhazur.  Multiple Regression in Behavioral Research: Explanation and Prediction , 1982 .

[3]  J. Kassubek,et al.  Standardized calculation of brain parenchymal fraction: an approach to objective assessment of cerebral atrophy. , 2003, AJNR. American journal of neuroradiology.

[4]  Jan Kassubek,et al.  Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study , 2003, Neuroreport.

[5]  Alan J Thompson,et al.  The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM‐based segmentation methodology , 2002, Journal of magnetic resonance imaging : JMRI.

[6]  J Kassubek,et al.  Topography of cerebral atrophy in early Huntington’s disease: a voxel based morphometric MRI study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[7]  H. Lerche,et al.  Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study , 2003, Neuroscience Letters.

[8]  Karl J. Friston,et al.  Spatial registration and normalization of images , 1995 .

[9]  B. Harper.  Huntington Disease , 2005, Journal of the Royal Society of Medicine.

[10]  V. Ho,et al.  Juvenile Huntington disease: CT and MR features. , 1995, AJNR. American journal of neuroradiology.

[11]  Lutz Jäncke,et al.  Brain size and grey matter volume in the healthy human brain , 2002, Neuroreport.

[12]  Suzanne E. Welcome,et al.  Mapping cortical change across the human life span , 2003, Nature Neuroscience.

[13]  S. Fahn,et al.  Huntington disease , 1979, Neurology.

[14]  N Makris,et al.  Evidence for more widespread cerebral pathology in early HD , 2003, Neurology.